Related Experiment Video
Updated: Nov 12, 2025
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes
Shih-Feng Chou1, Brandon A Caltrider1, Ali Azghani2
1Department of Mechanical Engineering, The University of Texas at Tyler, USA.
Insights
Modified polyurethane membranes can prevent blood clotting after vascular stenting. These materials reduce platelet activation and aggregation, offering a new approach to combat restenosis and improve cardiovascular disease outcomes.
Area of Science:
- Biomaterials Science
- Cardiovascular Research
- Biomedical Engineering
Background:
- Coronary thrombosis is a major cause of death in cardiovascular diseases.
- Vascular stenting can lead to restenosis due to platelet activation and aggregation.
- Both extrinsic and intrinsic pathways contribute to coagulation and platelet activation.
Purpose of the Study:
- To review mechanisms of platelet activation, adhesion, and aggregation.
- To discuss the use of modified polyurethane membranes for down-regulating platelet activity.
- To explore engineering approaches for vascular stent coatings to mitigate blood clotting.
Main Methods:
- Review of mechanisms of platelet activation and aggregation.
- Analysis of studies on polyurethane membranes with modified surface functional groups.
- Evaluation of the impact of hydrophilic and negatively charged surfaces on platelet signaling.
Main Results:
- Polyurethane membranes with hydrophilic and negatively charged surfaces reduce platelet adhesion and aggregation.
- Modified surfaces decrease αIIb-β3 signaling in activated platelets.
- These modifications offer a potential strategy to mitigate blood clotting.
Conclusions:
- Modified polyurethane membranes show promise in reducing platelet activity associated with vascular stenting.
- Surface engineering of biomaterials provides an effective approach to prevent restenosis.
- This strategy could significantly improve outcomes for patients undergoing vascular stent procedures.
Abstract:
Coronary thrombosis is one of the leading causes of mortality and morbidity in cardiovascular diseases, and patients who received vascular stent treatments are likely to suffer from restenosis due to tissue damage from stenting procedures (extrinsic pathway) and/or presence of unregulated factor XII (intrinsic pathway). Regardless of the pathway, coagulation factors and exposed collagen activate the G-protein-coupled receptors located at the plasma membrane of the resting platelets resulting in the change of their shapes with protrusions of filopodia and lamellipodia for surface adhesion. In this mini review, we discussed the mechanisms involved in platelet activation, adhesion, and aggregation. More importantly, we reviewed the use of polyurethane membranes with modified surface functional groups to down-regulate platelet adhesion and aggregation activities. Polyurethane membranes with hydrophilic and negatively charged surface properties showed a reduced αIIb-β3 signaling from the activated platelets, resulting in the decrease of platelet adhesion and aggregation. The use of polyurethane membranes with modified surface properties as coatings on vascular stents provides an engineering approach to mitigate blood clotting associated with restenosis.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...